| Bioactivity | PRL3-CNNM4 interaction-IN-1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction and also capable of inhibiting PRL-mediated inhibition of CNNM. PRL3-CNNM4 interaction-IN-1 exhibits favorable drug metabolism and pharmacokinetic properties[1]. | ||||||||||||
| CAS | 40133-06-0 | ||||||||||||
| Formula | C8H8O2S | ||||||||||||
| Molar Mass | 168.21 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Funato Y, et al. Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM[J]. Scientific Reports, 2024, 14(1): 25432. |
PRL3-CNNM4 interaction-IN-1
CAS: 40133-06-0 F: C8H8O2S W: 168.21
PRL3-CNNM4 interaction-IN-1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction and also capable of inhibiti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.